November 10, 2023 : Niterra, a global venture capital firm focused on innovative healthcare technologies, announced today that it has invested in Vivalink, a remote patient monitoring (RPM) startup. The investment will accelerate the development and deployment of Vivalink’s platform, enabling healthcare providers to monitor patients’ vital signs and other health data remotely.
Vivalink’s platform is powered by wearable biosensors that collect data on patients’ heart rate, blood pressure, respiratory rate, and other vital signs. The data is then transmitted to a cloud-based platform where healthcare providers can access it in real-time. This allows providers to identify and address potential health problems early on and provide more personalized patient care.
Niterra’s investment in Vivalink shows the growing interest in RPM technologies. RPM is increasingly being seen as a way to improve the quality of care for patients with chronic conditions, such as heart disease, diabetes, and COPD. RPM can also help to reduce healthcare costs by reducing the need for hospitalizations and other expensive forms of care.
Vivalink’s platform is well-positioned to meet the growing demand for RPM solutions. The platform is easy to use and affordable, and it offers a wide range of features that meet the needs of various healthcare providers.
Niterra’s investment in Vivalink will help accelerate the platform’s development and deployment. Niterra has a proven track record of success in investing in healthcare technologies, and it has the resources and expertise to help Vivalink achieve its growth goals.
Niterra’s investment in Vivalink is a positive development for the RPM market. It is a sign of the growing interest in RPM technologies, and it will help accelerate healthcare providers’ adoption of these technologies.